Shanghai ERP Biotechnology: difference between revisions
Diff·revision 42 → 43·13:21, 24 Dec 2025
Difference between revision 42 and revision 43 of Shanghai ERP Biotechnology. 5 lines changed; the page grew by 810 bytes.
| Revision 42 — 19:02, 18 Dec 2025 DeletionDeb (talk) fix significant figures — source gives fewer 8,936 bytes +228 | Revision 43 — 13:21, 24 Dec 2025 Ref_Desk_Ron (talk) fix arithmetic in worked example 9,746 bytes +810 | ||
|---|---|---|---|
| 70 | PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.{{r|tally}} | 70 | PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.{{r|tally}} |
| 71 | 71 | ||
| + | 72 | == Regulatory position and legal status == | |
| + | 73 | The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.{{r|registry}} | |
| + | 74 | ||
| + | 75 | Material labelled [[Research use only|for research use only]] is outside the regulatory framework that governs medicines. Its identity, purity, sterility and [[Bacterial endotoxin test|endotoxin]] content are not assured by any regulator, and a [[Certificate of analysis|certificate of analysis]] issued by a supplier is a claim by that supplier rather than an independent finding.{{r|ruo,usp1503}} | |
| + | 76 | ||
| 72 | == References == | 77 | == References == |
| 73 | {{reflist}} | 78 | {{reflist}} |